Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2

Drug Metabolism and Disposition(2020)10.1124/dmd.120.090720Source: DataRank Database

Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2 is a research paper published in Drug Metabolism and Disposition (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: bronzeTopics (33)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Raymond K. Hau ORCID,Joseph L. Jilek ORCID,Mark Morales,Stephen H. Wright ORCID,Nathan J. Cherrington ORCID

Live enrichment

PubMed:32393653 PMC:PMC7318791

NIEHS NIH HHS

Grant: P30 ES006694

NIGMS NIH HHS

Grant: R01 GM123643

NIGMS NIH HHS

Grant: R01 GM129777

NIEHS NIH HHS

Grant: T32 ES007091

National Institutes of Health

Grant: 2T32ES007091-36A1

Training in Environmental Toxicology of Human Disease

National Institutes of Health

Grant: 5R01GM123643-02

Circumventing the Blood-Testis Barrier

National Institutes of Health

Grant: 1R01GM129777-01A1

Improving In Vitro-In Vivo Extrapolation for Renal Cationic Drug Transport

bronzeLicense: Elsevier TDM

publisherhttps://dmd.aspetjournals.org/content/dmd/48/7/603.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0090955624080486?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955624080486?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/dmd.120.090720

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7318791

Fields of Study

0301 basic medicine03 medical and health sciencesBlood-Testis BarrierDrug Evaluation, PreclinicalEquilibrative Nucleoside Transporter 1Equilibrative-Nucleoside Transporter 2HeLa CellsHumansInhibitory Concentration 50NucleosidesReverse Transcriptase InhibitorsZidovudine

MeSH Terms

Blood-Testis BarrierHela CellsHumansNucleosidesEquilibrative Nucleoside Transporter 1Equilibrative-Nucleoside Transporter 2ZidovudineReverse Transcriptase InhibitorsDrug Evaluation, PreclinicalInhibitory Concentration 50HeLa Cells

Keywords

Equilibrative Nucleoside Transporter 1Inhibitory Concentration 50Drug Evaluation, PreclinicalHumansReverse Transcriptase InhibitorsNucleosidesEquilibrative-Nucleoside Transporter 2ZidovudineBlood-Testis BarrierHeLa Cells

Sustainable Development Goals

SDG 3: 3. Good health